Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Accumulated Expenses (2016 - 2020)

Historic Other Accumulated Expenses for AC Immune (ACIU) over the last 6 years, with Q1 2020 value amounting to $130264.7.

  • AC Immune's Other Accumulated Expenses changed N/A to $130264.7 in Q1 2020 from the same period last year, while for Mar 2020 it was $130264.7, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2018, which is 15004.95% up from last year.
  • AC Immune's Other Accumulated Expenses amounted to $130264.7 in Q1 2020.
  • Over the past 5 years, AC Immune's Other Accumulated Expenses peaked at $1.5 million during Q3 2017, and registered a low of -$709484.2 during Q2 2017.
  • Its 4-year average for Other Accumulated Expenses is $405995.3, with a median of $372276.4 in 2016.
  • As far as peak fluctuations go, AC Immune's Other Accumulated Expenses soared by 47067.06% in 2016, and later tumbled by 35308.57% in 2017.
  • Quarter analysis of 4 years shows AC Immune's Other Accumulated Expenses stood at $817020.0 in 2016, then crashed by 43.18% to $464219.3 in 2017, then surged by 145.68% to $1.1 million in 2018, then plummeted by 88.58% to $130264.7 in 2020.
  • Its last three reported values are $130264.7 in Q1 2020, $1.1 million for Q4 2018, and $464219.3 during Q4 2017.